Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018017994) COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/017994 International Application No.: PCT/US2017/043352
Publication Date: 25.01.2018 International Filing Date: 21.07.2017
IPC:
A61P 31/14 (2006.01) ,A61K 31/47 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12
Antivirals
14
for RNA viruses
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
Applicants:
JANSSEN PHARMACEUTICALS, INC. [US/US]; 1125 Trenton-Harbourton Road Titusville, NJ 08560, US
ACHILLION PHARMACEUTICALS, INC. [US/US]; 300 George Street New Haven, CT 06511, US
Inventors:
BEUMONT, Maria Gloria; FR
BIJNENS, Lieve; BE
BLATT, Lawrence M.; US
CHANDA, Sushmita Mukherjee; US
FRY, John; US
JANS, Eugene; BE
KAKUDA, Thomas Naoki; US
MAHADEVAN, Sivi; BE
MERTENS, Roel; BE
PICCHIO, Gaston Rafael; US
VAN DIJCK, Alex; US
VAN REMOORTERE, Peter; US
APELIAN, David; US
CHEN, Dawei; US
DESHPANDE, Milind; US
HUI, James; US
PHADKE, Avinash; US
Agent:
BELLOWS, Brent R.; US
ANDREANSKY, Eric S.; US
KNOWLES, Sherry M.; US
PROSSER, Anthony R.; US
Priority Data:
62/365,54122.07.2016US
PCT/US2016/05456129.09.2016US
Title (EN) COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION
(FR) TRAITEMENT PHARMACOLOGIQUE COMBINÉ DE L'INFECTION À HÉPATITE C
Abstract:
(EN) A method for the treatment of hepatitis C infection genotype 1, 2, 4, 5, or 6 is provided comprising administering an effective amount of a combination of Compound (I), Compound (II), and Compound (III), or independently optionally their pharmaceutically acceptable salt, solvate or hydrate, optionally in a solid fixed dose composition.
(FR) L'invention concerne une méthode de traitement du génotype 1, 2, 4, 5 ou 6 de l'infection à hépatite C, consistant à administrer une quantité efficace d'une combinaison de composé (I), de composé (II) et de composé (III), ou indépendamment, facultativement, de leur sel, solvate ou hydrate pharmaceutiquement acceptable, facultativement sous forme de composition solide à dose fixe.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)